Please enable JavaScript.
Coggle requires JavaScript to display documents.
HSC Conservation Plan - Coggle Diagram
HSC Conservation Plan
Expand research on the physiological effects of bleeding
How does bleeding effect the number of eggs a female HSC produces?
Are male and female HSCs impacted by bleeding differently?
Does bleeding make HSCs more vulnerable to diseases after release?
How quickly do HSCs recover their original blood volume?
Avoid conservation efforts that blame one industry entirely or suggest phasing one out
Blaming the bait industry only ostracizes fishermen as a potential collaborator and partner
To protect their livelihoods, increase efforts (e.g., research) to introduce an alternative, more sustainable eel and whelk bait source
Biomedical companies do not bleed HSCs for any nefarious purpose, but rather to provide a vital security to public health
Note that LAL tests phased out an unethical and unsustainable for endotoxin testing and that is rabbit pyrogen test (RPT)
This is not to say that the use, and perhaps mortality, of HSCs is more acceptable than that of a more stereotypically charisma species
Increase transparency
Have biomedical companies publicize their catch and release numbers on a quarterly to annual basis
Have biomedical companies publicize the details of their entire process from catch to release, including (but not limited to) transportation/holding times, distance between locations, temperatures at each stage
Have fisherman of HSCs for bait publicize their harvest numbers on a quarterly to annual basis
Give the ASMFC enforcing power
Standardize the biomedical best management practices outlined in 2022
Allow companies that do not follow these guidelines
Continue releasing publicly accessible stock assessment reports
Move towards recognizing rFC as a sufficient alternative to LAL
Introduce aquaculture-sourced LAL as a transitionary alternative in the meantime